For example, the use of the modified vaccinia ankara (MVA) virus expressing p53 is now used in combination with chemotherapy to treat ovarian cancer and with pembrolizumab to treat advanced breast/pancreatic/liver/head and neck cancer (Hardwick et al., 2018; Chung et al., 2019). This evidence concerns the gene TP53 and ovarian carcinoma.